Postoperative clinical outcomes with and without short-term intravenous tranexamic acid after posterior lumbar interbody fusion: A prospective cohort study

The use of tranexamic acid (TXA) in posterior lumbar interbody fusion (PLIF) surgery is believed to be beneficial for reducing intraoperative blood loss, postoperative drainage volume (PDV), and length of hospital stay (LOS). However, whether continued administration of intravenous TXA within 24 hou...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Xianqun, Wang, Xiaochen, Shi, Liang, Tian, Fangtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
7100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659680/
https://www.ncbi.nlm.nih.gov/pubmed/37986288
http://dx.doi.org/10.1097/MD.0000000000035911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659680/
https://www.ncbi.nlm.nih.gov/pubmed/37986288
http://dx.doi.org/10.1097/MD.0000000000035911

Ejemplares similares